Dr. Taylor Griffin Dickerson, MD

Dr. Dickerson practices at U.S. Dermatology Partners Tyler on Dominion Plaza in Tyler, Texas.

Dr. Dickerson's NPI, 1154825974, was assigned on March 19, 2018. Dr. Dickerson graduated from LSU Health Sciences Center New Orleans - School of Medicine in 2018. Dr. Dickerson holds Texas license T7197.

Dr. Dickerson's primary practice is U.S. Dermatology Partners Tyler on Dominion Plaza, at 1367 Dominion Plz, Tyler, TX 75703. The practice phone is (903) 534-6200.

Dr. Dickerson's primary practice is U.S. Dermatology Partners Tyler on Dominion Plaza in Tyler, Texas. The medical group on file is Wallis Dermatology Associates. Dmand AI also links Dr. Dickerson to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dickerson practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Dickerson's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Dickerson is board certified in dermatology by the American Board of Dermatology. Dr. Dickerson is licensed in Texas.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, facial skin infection and hives among the conditions Dr. Dickerson treats.

CMS data shows 4,806 Medicare services from Dr. Dickerson across 29 procedure codes in 2024, for 1,092 Medicare patients. Medicare paid $278,328 for them.

CMS counts 1,092 Medicare patients who saw Dr. Dickerson in 2024. The largest group is 65 to 74, with 505 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 2% are also on Medicaid. Their average risk score is 0.99, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dickerson's median patient age at 71, with 60% women.

In 2024, Dr. Dickerson wrote 1,820 Medicare Part D claims for 685 patients. 93% of them were for generic drugs. CMS names the drug for 1,616 of them, across 27 drugs with 11 or more claims each, at $453,519 in total drug cost. In 2023, CMS named 907 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Dickerson for performance year 2024, reported individually. Dr. Dickerson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 42 procedures of melanoma (skin cancer) excision by Dr. Dickerson, more than 84% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Dickerson in 2024. Dr. Dickerson has published most often in Cutis. Dr. Dickerson's most frequent co-authors are George M. Jeha, MD, Myriam Elizabeth Guevara, MD and Lyndsey Schexnayder Hargrave.

Dmand AI links Dr. Dickerson to 1 clinical trial. Conditions studied include Surgical Wound and Wounds and Injuries.

CMS Open Payments shows 406 general payments to Dr. Dickerson from 24 drug and device companies from 2021 to 2025. Speaker and faculty fees make up the largest share, 52% of the total. Bristol-Myers Squibb Company paid the most, $22,410.

Dmand AI lists 1 award for Dr. Dickerson, most recently All-American Scholar in 2012.

Dr. Dickerson graduated from LSU Health Sciences Center New Orleans - School of Medicine in 2018.

Dr. Dickerson is in network with 20 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.